Keeney S - Search Results

1

Development of resistance to activated protein C during pregnancy.

Cumming AM, Tait RC, Fildes S, Yoong A, Keeney S, Hay CR. Cumming AM, et al. Among authors: keeney s. Br J Haematol. 1995 Jul;90(3):725-7. doi: 10.1111/j.1365-2141.1995.tb05610.x. Br J Haematol. 1995. PMID: 7647019

2

The prothrombin gene G20210A variant: prevalence in a U.K. anticoagulant clinic population.

Cumming AM, Keeney S, Salden A, Bhavnani M, Shwe KH, Hay CR. Cumming AM, et al. Among authors: keeney s. Br J Haematol. 1997 Aug;98(2):353-5. doi: 10.1046/j.1365-2141.1997.2353052.x. Br J Haematol. 1997. PMID: 9266933 Free article.

3

The methylenetetrahydrofolate reductase gene C677T polymorphism in patients with homozygous sickle cell disease and stroke.

Cumming AM, Olujohungbe A, Keeney S, Singh H, Hay CR, Serjeant GR. Cumming AM, et al. Among authors: keeney s. Br J Haematol. 1999 Dec;107(3):569-71. doi: 10.1046/j.1365-2141.1999.01728.x. Br J Haematol. 1999. PMID: 10583261 Free article.

4

The prevalence of the cysteine1584 variant of von Willebrand factor is increased in type 1 von Willebrand disease: co-segregation with increased susceptibility to ADAMTS13 proteolysis but not clinical phenotype.

Bowen DJ, Collins PW, Lester W, Cumming AM, Keeney S, Grundy P, Enayat SM, Bolton-Maggs PH, Keeling DM, Khair K, Tait RC, Wilde JT, Pasi KJ, Hill FG; UK Haemophilia Centre Doctors' Organization. Bowen DJ, et al. Among authors: keeney s. Br J Haematol. 2005 Mar;128(6):830-6. doi: 10.1111/j.1365-2141.2005.05375.x. Br J Haematol. 2005. PMID: 15755288 Free article.

5

HLA class II profile: a weak determinant of factor VIII inhibitor development in severe haemophilia A. UKHCDO Inhibitor Working Party.

Hay CR, Ollier W, Pepper L, Cumming A, Keeney S, Goodeve AC, Colvin BT, Hill FG, Preston FE, Peake IR. Hay CR, et al. Among authors: keeney s. Thromb Haemost. 1997 Feb;77(2):234-7. Thromb Haemost. 1997. PMID: 9157572

6

Mutations in von Willebrand factor multimerization domains are not a common cause of classical type 1 von Willebrand disease.

Keeney S, Cumming A, Hay C. Keeney S, et al. Thromb Haemost. 1999 Nov;82(5):1446-50. Thromb Haemost. 1999. PMID: 10595636

7

The molecular biology of von Willebrand disease.

Keeney S, Cumming AM. Keeney S, et al. Clin Lab Haematol. 2001 Aug;23(4):209-30. doi: 10.1046/j.1365-2257.2001.00400.x. Clin Lab Haematol. 2001. PMID: 11683782 Review.

8

The C677T MTHFR variant and the risk of venous thrombosis.

Salden A, Keeney S, Hay CR, Cumming AM. Salden A, et al. Among authors: keeney s. Br J Haematol. 1997 Nov;99(2):472. Br J Haematol. 1997. PMID: 9375781 Free article. No abstract available.

9

The mutation spectrum associated with type 3 von Willebrand disease in a cohort of patients from the north west of England.

Sutherland MS, Keeney S, Bolton-Maggs PH, Hay CR, Will A, Cumming AM. Sutherland MS, et al. Among authors: keeney s. Haemophilia. 2009 Sep;15(5):1048-57. doi: 10.1111/j.1365-2516.2009.02059.x. Epub 2009 Jul 10. Haemophilia. 2009. PMID: 19601990

10

An investigation of the von Willebrand factor genotype in UK patients diagnosed to have type 1 von Willebrand disease.

Cumming A, Grundy P, Keeney S, Lester W, Enayat S, Guilliatt A, Bowen D, Pasi J, Keeling D, Hill F, Bolton-Maggs PH, Hay C, Collins P; UK Haemophilia Centre Doctors' Organisation. Cumming A, et al. Among authors: keeney s. Thromb Haemost. 2006 Nov;96(5):630-41. Thromb Haemost. 2006. PMID: 17080221

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

277 results

Search Page